Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr. Reddy’s Sees Profit Drop As Pricing Pressure Hits Generics Industry

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - India's second largest drug maker Dr. Reddy's Laboratories posted a 26 percent drop in quarterly profit partly due to pricing pressures in the generics business

You may also be interested in...



Dr. Reddy’s Bags Deal For Supply Of Generic Drugs To German Insurer AOK

MUMBAI - After a wait that lasted months, Dr. Reddy's Labs of India has bagged contracts for supplies of seven drugs to top German insurer AOK. AOK had called for bids from generic drug companies for a two-year contract valued at roughly € 2.3 billion ($2.98 billion) by financial analysts

Dr. Reddy’s Bags Deal For Supply Of Generic Drugs To German Insurer AOK

MUMBAI - After a wait that lasted months, Dr. Reddy's Labs of India has bagged contracts for supplies of seven drugs to top German insurer AOK. AOK had called for bids from generic drug companies for a two-year contract valued at roughly € 2.3 billion ($2.98 billion) by financial analysts

New Face For Dr Reddy’s Dermatology Business

MUMBAI - In what could be a significant push to its dermatology business in the U.S., Dr Reddy's Labs has carved out a new company - Promius Pharma to establish a distinct identity for its branded specialty products

Related Content

UsernamePublicRestriction

Register

LL038093

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel